← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-INOfficial filing linked
Jefferson Shreve disclosed SELL $BA
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2025-03-09
Trade date
2025-02-24
Disclosure lag
13 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 13 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
43 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Jefferson Shreve, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 19 lobbying filings.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20027879 · filed 2025-03-09 · disclosed 13d after transaction
Market context
Boeing Company
Sector: Industrials
Vs SPY: 9.5%
Factual flags
- 19 lobbying filings linked to this ticker.
- 3 nearby same-ticker disclosures in the surrounding 30-day window.
- 12 defense,airlines / transportation sector trades within 30 days while on relevant committee
- 66 trades filed on 2025-03-09 (batch dump)
- Sits on committee with jurisdiction over defense/airlines/transportation sector — traded BA on 2025-02-24
- Traded BA 8d after lobbying filing by THE BOEING COMPANY ($10,000) (committee overlap: Industrials)
Member trail
Jefferson Shreve
U.S. House · IN-6
House Committee on Transportation and InfrastructureHouse Committee on Foreign Affairs
Ticker trail
$BA
Boeing Company
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.